Mustang Bio (MBIO) Other Working Capital Changes (2017 - 2026)
Mustang Bio's (MBIO) quarterly Other Working Capital Changes came in at -$2000.0 in Q2 2026, up 94.87% year-over-year from -$1026.3 in Q2 2025, and up 33.33% quarter-over-quarter from -$3000.0 in Q1 2026.
Analysis
Mustang Bio (MBIO) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Other Working Capital Changes for 10 consecutive years, with -$2000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Working Capital Changes rose 94.87% year-over-year to -$2000.0 in Q2 2026; TTM through Jun 2026 was -$67000.0, a 215.52% decrease from a year earlier, with the FY2025 full-year figure at -$90000.0, up 84.64% from the prior year.
- Other Working Capital Changes was -$2000.0 for Q2 2026 at Mustang Bio, up from -$3000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.0 million in Q3 2023 and troughed at -$2.8 million in Q4 2023.
- A 5-year average of -$42611.1 and a median of -$21000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 363.87% in 2022 and tumbled 7822.22% in 2023, its largest moves.
- Over 5 years, Other Working Capital Changes stood at $36000.0 in 2022, then plunged by 7822.22% to -$2.8 million in 2023, then surged by 104.17% to $116000.0 in 2024, then sank by 143.1% to -$50000.0 in 2025, then surged by 96.0% to -$2000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$2000.0 (Q2 2026), -$3000.0 (Q1 2026), and -$50000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Mustang Bio | 3.50 Mn | 3.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,000.00 |
| Jun 30, 2026 | -2,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -301,000.00 |
| Jun 30, 2024 | -301,000.00 |
| Mar 31, 2024 | -371,000.00 |
| Mar 31, 2024 | -371,000.00 |